13120-77-9

Basic information

• Product Name: 2-Methyl-5-nitroanisole
• Synonyms: 2-methoxy-1-methyl-4-nitro-benzen;1-METHOXY-2-METHYL-5-NITROBENZENE;2-METHYL-5-NITROANISOLE;2-METHOXY-4-NITROTOLUENE;2-METHOXY-1-METHYL-4-NITRO-BENZENE;methyl 5-nitro-o-tolyl ether;5-Nitro-2-MethylAnisole;2-METHYL-5-NITROANISOLE 99%
• CAS NO: 13120-77-9
• Molecular Formula: C₈H₉NO₃
• Molecular Weight: 167.16
• EINECS: 236-048-6
• Product Categories: Aromatic Hydrocarbons (substituted) & Derivatives;Anisole;Anisoles, Alkyloxy Compounds & Phenylacetates;Nitro Compounds;Nitro Compounds;Nitrogen Compounds;Organic Building Blocks
• Mol File: 13120-77-9.mol
• Article Data: 5

Chemical Properties

• Melting Point: 69-71 °C(lit.)
• Boiling Point: 281.2 °C at 760 mmHg
• Flash Point: 135.5 °C
• Appearance: /
• Density: 1.18 g/cm3
• Vapor Pressure: 0.00614mmHg at 25°C
• Refractive Index: 1.538
• Storage Temp.: Sealed in dry,Room Temperature
• Solubility: soluble in Methanol
• CAS DataBase Reference: 2-Methyl-5-nitroanisole(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Methyl-5-nitroanisole(13120-77-9)
• EPA Substance Registry System: 2-Methyl-5-nitroanisole(13120-77-9)

Safety Data

• Hazard Codes: Xn,Xi
• Statements: 22-36/37/38
• Safety Statements: 24/25-36-26
• WGK Germany: 3
• Hazardous Substances Data: 13120-77-9(Hazardous Substances Data)

Usage

Uses

Different sources of media describe the Uses of 13120-77-9 differently. You can refer to the following data:
1. 2-Methyl-5-nitroanisole is a useful research chemical.
2. 2-Methyl-5-nitroanisole was used in the synthesis of:2-methoxy-p-toluidine via reduction with tin and hydrochloric acid2-methoxy-4-nitrobenzyl bromide

Chemical Properties

cream to yellow crystalline powder and chunks

InChI:InChI=1/C8H9NO3/c1-6-3-4-7(9(10)11)5-8(6)12-2/h3-5H,1-2H3

Upstream product

• 67-56-1 methanol 
• 1427-07-2 2-fluoro-4-nitrotoluene 
• 124-41-4 sodium methylate 
• 5428-54-6 2-methyl-5-nitrophenol 
• 77-78-1 dimethyl sulfate 
• 74-88-4 methyl iodide 
• 518990-51-7 acetic acid-(4-methoxy-5-methyl-2-nitro-anilide) 
• 31910-25-5 N-(4-methoxy-3-methylphenyl)acetamide 
• 80-48-8 methyl p-toluene sulfonate 
• 55730-09-1 4-methoxy-5-methyl-2-nitroaniline 

Downstream Products

• 198821-77-1 (2-methoxy-4-nitrophenyl)methylene diacetate 
• 101281-06-5 4.4'-dinitro-2.2'-dimethoxy-dibenzyl 
• 16452-01-0 ortho-cresidine 
• 72856-73-6 2-methoxy-4-(methylsulfanyl)benzoic acid 
• 860734-17-4 4,5-dinitro-2-methylanisole 
• 101118-65-4 α,α'-dibromo-2,2'-dimethoxy-4,4'-dinitro-bibenzyl 
• 1196-65-2 4-amino-2-methoxybenzaldehyde 
• 861609-18-9 6-methyl-2,3,4-trinitro-anisole 
• 136507-15-8 4-nitro-2-methoxybenzaldehyde 
• 2597-56-0 4-nitro-o-anisic acid 
• 90434-16-5 1-(bromomethyl)-2-methoxy-4-nitrobenzene 

Relevant articles and documents

Synthesis of 2-Methoxy-4-(methylsulfanyl)benzoic Acid — An Intermediate Product in the Preparation of the Cardiotonic Drugs Sulmazole and Isomazole

Readily available 4-methyl-3-nitrobenzenesulfonic acid and 2-methyl-5-nitrophenol were used to develop two alternative approaches to the synthesis of 2-methoxy-4-(methylsulfanyl)benzoic acid in total yields of 17% and 37%, respectively. The synthesis starting from 2-methyl-5-nitrophenol is more process-oriented and can be used in the resynthesis of Sulmazole and Isomazole.

Peroxisome proliferator-activated receptor agonists with phenethylphenylphthalimide skeleton derived from thalidomide-related liver X receptor antagonists: Relationship between absolute configuration and subtype selectivity

Introduction of an alkylcarboxylic acid unit, which is a partial structure of endogenous peroxisome proliferator-activated receptor (PPAR) ligands, into a phenethylphenylphthalimide skeleton, which possesses liver X receptor (LXR) antagonistic activity, afforded novel PPAR ligands. The results of structure-activity relationship analysis and docking studies led us to the potent PPAR agonists 13c-e. The absolute configuration of 13c-e affects the PPAR subtype selectivity.

Nitroaryl phosphoramide compositions and methods for targeting and inhibiting undesirable cell growth or proliferation

The present invention relates to nitroaryl-substituted phosphoramide prodrug compounds and methods of producing the same for use in targeting and inhibiting undesirable cell growth or proliferation.